Huitai Medical: Revenue of 1.526 billion yuan in the first half of 2026, net profit up 26.38% year-on-year.

Huitai Medical announced that the company voluntarily disclosed its production and operating conditions. In the first half of 2026, it achieved operating revenue of 1.526 billion yuan, a year-on-year increase of 25.75%; net profit attributable to shareholders of the listed company was 537 million yuan, a year-on-year increase of 26.38%; total profit was 603 million yuan, a year-on-year increase of 25.84%. In the first three quarters of 2026, the growth rates of revenue and net profit increased compared with the first half of the year. For details, please refer to the 2026 third quarter report to be disclosed on October 29. Since its listing, the company has implemented four rounds of buybacks, with a cumulative buyback amount exceeding 600 million yuan; from 2020 to 2025, cumulative cash dividends totaled 653 million yuan.